Page 11 - Practical Considerations to Health Professional-Led Advocacy

The Challenge

There are many stakeholders with different interests.

Patients: Have the most vested interest

Advocacy groups: Equal and timely access to effective treatments to improve
patient outcomes

Pharmaceutical/Biotech Cos: Access to innovative treatments
Physicians: Treatment options for best outcome

Healthcare providers: Best treatments within their system and budget
Regulators: Fairness and diligence in assessing the risk/benefit ratio according to

their methods of appraisal
Government agencies: Policy and direction on best spending practices to ensure

overall population good health
Third-party payers: Best value from available funds when covering prescription

choices